Persistent Hib Invasive Disease and Rising Dominance of Highly Resistant NTHi in Chinese Children: A Retrospective Single-Centre Study, 2013–2023

In the human nose and throat, a tiny bacterium called Haemophilus influenzae often lives quietly, harmless to its host. For most people, it is simply a neighbor in the microbial community. However, when this bacterium slips past the body's defenses and enters the blood, the lungs, or the fluid surrounding the brain, it can cause severe, life-threatening illness. Scientists have long known that this bacterium comes in different "flavors." Some are wrapped in a slippery, sugary coat that acts like a shield, allowing them to hide from the immune system; these are called encapsulated strains. Others lack this coat entirely. For decades, the most dangerous of the coated varieties, known as type b, was the primary cause of severe childhood infections like meningitis. The medical world responded by creating a vaccine that teaches the body to recognize and destroy this specific coated version. While this vaccine has been available in China for over twenty years, it is not part of the free, mandatory schedule for all children, meaning many families must pay for it themselves. This patchwork coverage has left a complex question: has the vaccine worked well enough to stop the dangerous coated bacteria, and what has happened to the uncoated versions that remain?

A team of researchers at Beijing Children's Hospital set out to answer this by looking at a decade of real-world infections. They gathered 111 samples of the bacteria taken from children who were genuinely sick, not just carrying the germ in their nose. These samples came from sterile places like blood and spinal fluid, as well as from middle ear fluid and deep lung washings, ensuring that every bacterium they studied was the actual cause of the child's illness. The study covered the years from 2013 to 2023, a period long enough to see how the bacteria changed over time. The researchers examined each sample to determine its type, tested how well it survived against common antibiotics, and mapped its genetic family tree to see which strains were spreading.

The results revealed a story of two different bacterial populations. The researchers found that the dangerous, coated type b bacteria, which the vaccine targets, had not disappeared. In fact, among the children with the most severe, invasive infections, the coated type b was still a major culprit, appearing in more than half of those cases. These severe cases happened almost exclusively in very young children, mostly under the age of one. The genetic analysis showed that these dangerous bacteria were not random; they belonged to a specific, tight-knit family group that had been circulating for a long time. This suggests that because the vaccine is not given to every child, this specific, dangerous family of bacteria continues to find enough unvaccinated hosts to keep spreading. The researchers also found a few cases of another coated type, type f, which is becoming more recognized as a threat in other parts of the world.

While the coated bacteria remained a serious problem for the youngest patients, the uncoated version of the bacteria, known as non-typeable Haemophilus influenzae, had taken over as the dominant player overall. This uncoated strain was found in nearly all the children with ear infections and pneumonia, and it was also responsible for nearly half of the severe invasive cases. What made this uncoated strain particularly concerning was its resistance to medicine. The researchers tested how the bacteria reacted to standard antibiotics and found that the uncoated strains were far more difficult to treat than the coated ones. They were much more likely to survive doses of ampicillin and azithromycin, two drugs often used as a first line of defense.

The study dug deeper to understand why these uncoated bacteria were so tough. They found that the majority of these resistant strains carried a specific genetic change that altered the target of the antibiotics, making the drugs less effective. Furthermore, a specific family group of these uncoated bacteria, which the researchers identified as a distinct genetic cluster, was responsible for a large portion of the resistant cases. This particular group was uniformly resistant to beta-lactam antibiotics, a broad class of drugs that includes penicillin and amoxicillin. It was as if this specific family had evolved a perfect defense mechanism, combining a shield against the drug's attack with a genetic mutation that blocked the drug's entry. This combination made them significantly harder to kill than the older, coated strains.

The findings paint a clear picture of the current landscape in Chinese children. The vaccine has not eliminated the disease, and the dangerous coated bacteria remain a primary cause of severe infection in infants, supporting the argument for making the vaccine available to all children without cost. At the same time, the uncoated bacteria have become the most common cause of infection overall, and they are evolving to resist the antibiotics doctors currently rely on. The study did not find that the vaccine caused the rise of the uncoated bacteria, but it did show that as the coated bacteria are pushed back in some areas, the uncoated ones fill the gap, bringing a new set of challenges with their high resistance rates. The researchers concluded that to protect children, the medical community needs to do two things: ensure every child receives the vaccine against the coated type, and develop new vaccines specifically designed to target the uncoated, resistant strains that are now dominating the landscape.